Last updated on February 2018

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone ) on the Clearance of Verruca Vulgaris (Common Warts)


Brief description of study

Warts are benign epidermal tumors caused by human papillomaviruses (HPVs). The active pharmaceutical ingredient DPCP has been used for many years as a compounded formulation in acetone for the treatment of warts, alopecia areata and more recently, cutaneous metastatic melanoma lesions. An improved topical ointment formulation of DPCP called Samcyprone will be evaluated for the treatment of common warts.

Clinical Study Identifier: NCT02640820

Contact Investigators or Research Sites near you

Start Over

International Dermatology Research
Miami, FL United States

Summit Dermatology
Oakbrook Terrace, IL United States

Dawes Fretzin Clinical Research Group
Indianapolis, IN United States

Mount Sinai - St. Luke's
New York, NY United States